https://www.prnewswire.com/news-releases/fosun-pharma-and-maia-pharmaceuticals-jointly-announce-the-successful-commercialization-of-only-fda-approved-20ml-sodium-phenylacetate-and-sodium-benzoate-spsb-liquid-product-301633154.html
/PRNewswire/ -- Shanghai Fosun Pharma (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced that the 20 ml, Sodium...
fosun pharmamaiapharmaceuticalsjointlyannounce
https://agnopharma.com/
Agno Pharma: A leading Pharmaceutical CDMO & CMO in the US and China. We take your product from formulation, to development and manufacturing, to...
formulation developmentagnopharmacdmocmo